Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drugs psychoactive

Stimulation of appetite and weight gain has frequently been observed as a side effect of long-term therapy with various psychoactive drugs. Prominent examples not... [Pg.212]

H.17 The psychoactive drug sold as methampheramine ( speed ), CI0H,N, undergoes a series of reactions in the body the net result of these reactions is the oxidation of solid methamphetamine by oxygen gas to produce carbon dioxide gas, liquid water, and nitrogen gas. Write the balanced equation for this net reaction. [Pg.89]

Hummel D, Loffler D, Fink G, Temes TA (2006) Simultaneous determination of psychoactive drugs and their metabolites in aqueous matrices by liquid chromatography mass spectrometry. Environ Sci Technol 40 7321-7328... [Pg.225]

Wesson DR, Ling W The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs 35 253-259, 2003... [Pg.109]

Apsler R, Rothman E Correlates of compliance with psychoactive prescriptions. J Psychoactive Drugs 16 193—199, 1984... [Pg.148]

Gottschalk LA, Bates DE, Fox RA, et al Psychoactive drug use patterns found in samples from a mental health clinic and a general medical clinic. Arch Gen Psychiatry 25 395-397, 1971... [Pg.153]

Silberstein SD, McCrory DC Butalbital in the treatment of headache history, pharmacology, and efficacy. Headache 41 953-967, 2001 Smith DE, Wesson DR Benzodiazepine dependency syndromes. J Psychoactive Drugs 15 85-95, 1983... [Pg.160]

Boyer EW, Quang L, Woolf A, et al Use of physostigmine in the management of gamma-hydroxybutyrate overdose (letter). Ann Emerg Med 38 346, 2001 Buffiim J, Moser C MDMA and human sexual dysfunction. J Psychoactive Drugs 18 355-359, 1986... [Pg.261]

McDaniel CH, Miotto KA Gamma hydroxybutyrate (GHB) and gamma butyrolac-tone (GBL) withdrawal five case studies. J Psychoactive Drugs 33 143—149,2001... [Pg.264]

Doble, A and Martin, IL (1996) The GABAjijBenzodiazepine Receptor as a Target for Psychoactive Drugs, RG Landes Co., Austin, TX. [Pg.421]

We have talked with people who participated in our study over the last year. As you know, many of them have experimented with a wide variety of psychoactive drugs, including MBDB. When asked about MBDB their response seems to be lukewarm in terms of how it compares to subjective effects, and whether these effects are comparable to those of MDMA. Is that accurate ... [Pg.22]

Greer, G., and Tolbert, R. Subjective reports of the effects of MDMA in a clinical setting. J Psychoactive Drugs 18 319-327, 1986. [Pg.26]

Nichols, DE. Differences between the mechanisms of action of MDMA, MBDB, and the classical hallucinogens. Identification of a new therapeutic class Entactogens. J Psychoactive Drugs 18 305-313, 1986. [Pg.26]

Siegel, R.K. MDMA Nonmedical use and intoxication. J Psychoactive Drugs 18 349-354, 1986,... [Pg.27]

Downing, J. The psychological and physiological effects of MDMA on normal volunteers. J Psychoactive Drugs 18 35-340, 1986. [Pg.40]

Shulgin, A.T. The background and chemistry of MDMA. J Psychoactive Drugs 18 191-205, 1986. [Pg.41]

The goal of this chapter is to review recent morphologic studies in which current anatomic me ods have been used to characterize the neurotoxic effects of psychoactive amphetamine derivatives. Several strategies combining anatomic with biochemical data have been employed to analyze the effects of selected drugs in this class. These studies show that psychoactive drugs that have selective neurotoxic effects can be useful experimental tools to study the neural mechanisms of elusive brain functions such as affective state control and perceptual integration. [Pg.270]

It is not uncommon for individuals under the influence of phencyclidine to come to the attention of the criminal justice system. Increasingly, there is a need for forensic experts to advise and testify in cases involving PCP and other psychoactive drugs. With the publication of a paper on acute intoxication and fatalities from PCP use, we began to receive requests from attorneys to evaluate PCP-related cases (Burns et al. 1975). We have now consulted in over 400 civil and criminal cases and have testified in municipal, superior, and Federal courts from Hawaii to Washington, D.C. [Pg.242]

As we have seen, low doses of caffeine (75 to 300 mg) have been shown to increase positive mood states,153 with higher doses leading to more and more positive mood states, at least up to a point.155-265 At the very high levels of consumption (greater than 500 mg) seen in heavy caffeine users,157 the drug can elevate anxiety and depress affect.34 Our more general review of the mood state literature above leaves little doubt that caffeine is a psychoactive drug. [Pg.280]

Zaslav, M., Psychology or comorbid posttraumatic stress disorder and substance abuse lessons for combat veterans. J Psychoactive Drugs 26(4), 393-400, 1994. [Pg.299]

Wurl.P., Life threatening caffeine poisoning by using coffee as a psychoactive drug. Wien Klin Wochenschr 106(11), 359-361, 1994. [Pg.303]

Nation JR Texas A M University Health Science Center, College Station, TX Heavy metals and cocaine interactions possible link between xenobiotic contamination and the response to a prominently abused psychoactive drug National Institute on Drug Abuse... [Pg.365]

Hershkowitz, M. and Szechtman, H., Pretreatment with A1 tetrahydrocannabinol and psychoactive drugs effects on uptake of biogenic amines and on behavior, Eur. J. Pharm., 59, 267, 1979. [Pg.17]

Anglin, M.D., Burke, C., Perrochet, B., Stamper, E., Dawud-Noursi, S. History of the methamphetamine problem. J. Psychoactive Drugs 32 137, 2000. [Pg.66]

Doblin, R., A clinical plan for MDMA (Ecstasy) in the treatment of posttraumatic stress disorder (PTSD) partnering with the FDA, J. Psychoactive Drugs 34(2), 185-94, 2002. [Pg.135]


See other pages where Drugs psychoactive is mentioned: [Pg.834]    [Pg.910]    [Pg.404]    [Pg.2]    [Pg.27]    [Pg.28]    [Pg.28]    [Pg.101]    [Pg.148]    [Pg.165]    [Pg.242]    [Pg.36]    [Pg.104]    [Pg.135]    [Pg.1]    [Pg.3]    [Pg.3]    [Pg.3]    [Pg.4]    [Pg.4]    [Pg.4]   
See also in sourсe #XX -- [ Pg.3 , Pg.4 , Pg.5 , Pg.6 , Pg.7 ]

See also in sourсe #XX -- [ Pg.62 ]

See also in sourсe #XX -- [ Pg.112 ]

See also in sourсe #XX -- [ Pg.497 , Pg.507 ]

See also in sourсe #XX -- [ Pg.1038 , Pg.1287 ]

See also in sourсe #XX -- [ Pg.247 ]

See also in sourсe #XX -- [ Pg.32 , Pg.35 ]

See also in sourсe #XX -- [ Pg.103 ]

See also in sourсe #XX -- [ Pg.497 , Pg.498 , Pg.499 , Pg.500 , Pg.501 , Pg.502 , Pg.503 , Pg.504 , Pg.505 , Pg.506 ]

See also in sourсe #XX -- [ Pg.35 , Pg.87 , Pg.88 ]




SEARCH



Antidepressants psychoactive drugs

Drugs, psychoactive, inhibition

Journal of Psychoactive Drugs

NIMH Psychoactive Drug Screening

Non-medical Use of Psychoactive Drugs

PSYCHOACTIVE DRUGS ALTER THE MIND OR BEHAVIOR

Psychoactive

Psychoactive drugs actions

Psychoactive drugs administration

Psychoactive drugs classes

Psychoactive drugs concepts

Psychoactive drugs depressants

Psychoactive drugs effects

Psychoactive drugs hallucinogens

Psychoactive drugs introduction and overview

Psychoactive drugs stimulants

Psychoactive drugs symptoms

Toxic substances, psychoactive drugs

© 2024 chempedia.info